Clove+ as a Multi-Botanical Herbaceutical for Gut and Skin Wellness: A Narrative Review of Ingredient-Level Evidence and Convergent Mechanisms

Abstract

Clove+ is a multi-botanical capsule positioned for daily gut and skin wellness and formulated with coconut-derived medium-chain triglyceride (MCT), rosemary, garlic, Aloe vera, cinnamon, onion-derived quercetin, clove, thyme, grape seed extract and beetroot. The product is positioned for adult daily wellness use, with the supplied label specifying one capsule daily or as advised by a healthcare professional and stating that it is not intended to diagnose, treat, cure or prevent disease. This narrative review evaluates existing ingredient-level evidence relevant to the formulation’s wellness positioning. Human studies support gastrointestinal or microbiome relevance for cinnamon, garlic and Aloe vera; skin hydration and elasticity outcomes for defined oral Aloe preparations; antioxidant biomarker effects for clove and grape-seed preparations; and photoprotective outcomes for a rosemary-containing oral polyphenol combination. Mechanistic evidence extends to defined cellular and subcellular targets. Quercetin regulates intestinal tight-junction proteins; garlic-derived allicin modifies cysteine thiols in human proteins and activates Nrf2/HO-1-associated epithelial antioxidant responses; grape-seed proanthocyanidins influence mitochondrial redox function and epithelial barrier integrity; clove/eugenol and rosemary carnosic acid regulate matrix metalloproteinases and redox-sensitive signalling in skin cells; and Aloe acemannan influences fibroblast proliferation, growth-factor expression and type-I collagen. Together, the evidence supports a coherent ingredient-level rationale for digestive comfort, a balanced gastrointestinal environment, mucosal homeostasis, antioxidant defence and selected aspects of skin wellness. The evidence does not establish disease treatment, genomic modification or finished-product clinical efficacy.